Literature DB >> 7127000

The effects of vasoactive intestinal polypeptide and of adenosine 5'-triphosphate on the isolated anococcygeus muscle of the mouse.

A Gibson, J F Tucker.   

Abstract

1 Vasoactive intestinal polypeptide (VIP, 0.01- MicroM) produced dose-related relaxations of the mouse anococcygeus muscle. 2 Following incubation with indomethacin (2.8 microM 1 h) adenosine 5'-triphosphate (ATP, 0.5-10 mM) produced dose-related relaxations of the mouse anococcygeus. 3 Haemolysed blood reduced inhibitory responses of the mouse anococcygeus to field stimulation but had no effect on relaxations to VIP or ATP. 4 Apamin (0.5 microM) had no effect on the relaxation of mouse anococcygeus to field stimulation, VIP, or ATP. 5 2-2'-Pyridylisatogen tosylate (PIT, 50 microM) itself reduced muscle tone but it did not abolish inhibitory responses to field stimulation, VIP, or ATP. 6 During prolonged inhibitory nerve stimulation the relaxation of the mouse anococcygeus in response to VIP was reduced greatly while that to ATP was unaffected. 7 Bundles of VIP-immunoreactive sites were detected in sections of the mouse anococcygeus treated by the peroxidase-antiperoxidase (PAP) immunocytochemical technique. 8 The results suggest that the mechanisms underlying non-adrenergic, non-cholinergic inhibitory transmission in the mouse anococcygeus are similar to those in the bovine retractor penis and unlike those in the guinea-pig taenia caeci. 9 The possibility that VIP or ATP might be involved in inhibitory neurotransmission in the mouse anococcygeus is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127000      PMCID: PMC2044660          DOI: 10.1111/j.1476-5381.1982.tb09274.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Identification of separate receptors for adenosine and adenosine 5'-triphosphate in causing relaxations of the isolated taenia of the guinea-pig caecum.

Authors:  M Spedding; D F Weetman
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

2.  The nature of potassium chloride-induced relaxations of the rat anococcygeus muscle.

Authors:  A Gibson; T A James
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

Review 3.  Purinergic nerves.

Authors:  G Burnstock
Journal:  Pharmacol Rev       Date:  1972-09       Impact factor: 25.468

4.  Evidence for purinergic innervation of the anococcygeus muscle.

Authors:  G Burnstock; T Cocks; R Crowe
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

5.  Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.

Authors:  M G Bryant; M M Polak; I Modlin; S R Bloom; R H Albuquerque; A G Pearse
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

6.  Vasoactive intestinal polypeptide excites neurones of the myenteric plexus.

Authors:  J T Williams; R A North
Journal:  Brain Res       Date:  1979-10-12       Impact factor: 3.252

7.  Nucleotide pyrophosphatase antagonizes responses to adenosine 5'-triphosphate and non-adrenergic, non-cholinergic inhibitory nerve stimulation in the guinea-pig isolated taenia coli.

Authors:  D G Satchell
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

8.  Quinacrine-binding nerves: presence in the mouse ano-coccygeus muscle, disappearance after muscle transsection.

Authors:  L Olson; M Alund
Journal:  Med Biol       Date:  1979-06

9.  Evidence against vasoactive intestinal polypeptide being the non-adrenergic, non-cholinergic inhibitory transmitter released from nerves supplying the smooth muscle of the guinea-pig taenia coli.

Authors:  I Mackenzie; G Burnstock
Journal:  Eur J Pharmacol       Date:  1980-10-17       Impact factor: 4.432

10.  VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurones.

Authors:  R K Goyal; S Rattan; S I Said
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

View more
  9 in total

1.  Innervation of the anococcygeus muscle of the rat.

Authors:  W G Dail; Y Carrillo; G Walton
Journal:  Cell Tissue Res       Date:  1990-01       Impact factor: 5.249

Review 2.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

3.  Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.

Authors:  B F King; C Dacquet; A U Ziganshin; D F Weetman; G Burnstock; P M Vanhoutte; M Spedding
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  N-methylhydroxylamine inhibits and M&B 22948 potentiates relaxations of the mouse anococcygeus to non-adrenergic, non-cholinergic field stimulation and to nitrovasodilator drugs.

Authors:  A Gibson; S Mirzazadeh
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

5.  An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus.

Authors:  A Gibson; R Babbedge; S R Brave; S L Hart; A J Hobbs; J F Tucker; P Wallace; P K Moore
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

6.  Neuropeptide-induced contraction and relaxation of the mouse anococcygeus muscle.

Authors:  A Gibson; H A Bern; M Ginsburg; J H Botting
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Potassium induces relaxation and hyperpolarization of circular muscles but contraction of longitudinal muscles of pig duodenum.

Authors:  I Kimura; M Kimura; M Kimura
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

8.  Biphasic non-adrenergic, non-cholinergic relaxations of the mouse anococcygeus muscle.

Authors:  A Gibson; O Yu
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

9.  Evidence for coexistence of ATP and nitric oxide in non-adrenergic, non-cholinergic (NANC) inhibitory neurones in the rat ileum, colon and anococcygeus muscle.

Authors:  A Belai; G Burnstock
Journal:  Cell Tissue Res       Date:  1994-10       Impact factor: 5.249

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.